# ETFs That Hold BioCryst Pharmaceuticals Inc (BCRX)

> 54 US listed ETFs hold BioCryst Pharmaceuticals Inc, most of all PBE at 2.33% of the fund. Weights and filing dates for every holder.

Data as of Oct 15, 2026. Rebuilt every trading night.

## ETFs that hold BioCryst Pharmaceuticals Inc

54 US listed ETFs hold BioCryst Pharmaceuticals Inc. PBE holds the most, at 2.33% of the fund.

### Every fund that holds it

| Fund | Name | Share of the fund | Holdings filed | Asset |
| --- | --- | --- | --- | --- |
| PBE | Invesco Biotechnology & Genome ETF | 2.33% | Oct 13, 2026 | Equity |
| BBP | Virtus Biotech ETF | 1.42% | Jul 31, 2026 | Equity |
| ABLS | Abacus FCF Small Cap Leaders ETF | 0.99% | Jul 31, 2026 | Equity |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 0.92% | Jul 31, 2026 | Equity |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 0.61% | Jul 31, 2026 | Equity |
| XBI | State Street(R) SPDR(R) S&P(R) Biotech ETF | 0.58% | Oct 13, 2026 | Equity |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.26% | Jun 30, 2026 | Equity |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.25% | Oct 13, 2026 | Equity |
| BFOR | Barron's 400 ETF | 0.25% | May 31, 2026 | Equity |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.22% | Oct 13, 2026 | Equity |
| IVSS | Applied Finance IVS US SMID ETF | 0.21% | Jun 30, 2026 | Equity |
| GSSC | GS ActiveBeta U.S. Small Cap Equity ETF | 0.19% | May 31, 2026 | Equity |
| PSC | Principal U.S. Small-Cap ETF | 0.19% | Jun 30, 2026 | Equity |
| PWS | Pacer WealthShield ETF | 0.17% | Jul 31, 2026 | Equity |
| TPSC | Timothy Plan US Small Cap Core ETF | 0.17% | Jun 30, 2026 | Equity |
| ISMD | Inspire Small/Mid Cap ETF | 0.16% | May 31, 2026 | Equity |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | 0.15% | Jun 30, 2026 | Equity |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.15% | Oct 13, 2026 | Equity |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.14% | Oct 13, 2026 | Equity |
| ESSC | Eventide Small Cap ETF | 0.14% | Jul 31, 2026 | Equity |
| IBB | iShares Biotechnology ETF | 0.13% | Oct 13, 2026 | Equity |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.12% | Sep 30, 2026 | Equity |
| FESM | Fidelity Enhanced Small Cap Core ETF | 0.12% | Jun 30, 2026 | Equity |
| IWO | iShares Russell 2000 Growth ETF | 0.12% | Oct 13, 2026 | Equity |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.12% | Jul 31, 2026 | Equity |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.11% | Jul 31, 2026 | Equity |
| ACSG | American Century Small Cap Growth Insights ETF | 0.10% | May 31, 2026 | Equity |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.08% | Oct 14, 2026 | Equity |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.07% | Jun 30, 2026 | Equity |
| RSSL | Global X Russell 2000 ETF | 0.07% | Jul 31, 2026 | Equity |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.06% | Oct 13, 2026 | Equity |
| VTWO | Vanguard Russell 2000 ETF | 0.06% | Sep 30, 2026 | Equity |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.06% | Oct 13, 2026 | Equity |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.06% | Oct 13, 2026 | Equity |
| IWM | iShares Russell 2000 ETF | 0.06% | Oct 13, 2026 | Equity |
| ITWO | ProShares Russell 2000 High Income ETF | 0.05% | May 31, 2026 | Equity |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.05% | Oct 13, 2026 | Equity |
| SCHA | Schwab U.S. Small-Cap ETF | 0.04% | May 31, 2026 | Equity |
| ISCB | | 0.03% | Jul 31, 2026 | Equity |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | 0.03% | Sep 30, 2026 | Equity |
| FHLC | Fidelity MSCI Health Care Index ETF | 0.03% | Jul 31, 2026 | Equity |
| VXF | Vanguard Extended Market ETF | 0.02% | Sep 30, 2026 | Equity |
| VHT | Vanguard Health Care ETF | 0.02% | Sep 30, 2026 | Equity |
| VB | Vanguard Morningstar Small-Cap ETF | 0.01% | Sep 30, 2026 | Equity |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 0.01% | May 31, 2026 | Equity |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% | Oct 13, 2026 | Equity |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.01% | May 31, 2026 | Equity |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% | Oct 13, 2026 | Equity |
| ESGV | Vanguard ESG U.S. Stock ETF | BioCryst Pharmaceuticals Inc (ticker BCRX, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Each row shows the date the fund last filed.

Look up another company .

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, ETFs holding BioCryst Pharmaceuticals Inc, data as of Oct 15, 2026. https://etfiq.com/holdings/bcrx/
Licence: https://etfiq.com/license/ Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/holdings/bcrx/